LL-37 acid LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-acid

Description

Broad-spectrum anti-microbial activity. Produced in human epithelial cells

See full description

Catalogue number crb1000007
Sequence (one letter code) LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-acid
Sequence (three letter code) H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH
Aliases hCAP18
Purity >95%
Storage - 20 ° C
Molecular Weight 4490.6
References

Singh et al (2014) LL-37 Peptide Enhancement of Signal Transduction by Toll-like Receptor 3 Is Regulated by pH. J. Biol. Chem. 289(40) 27614 PMID: 25092290

Tripathi et al (2014) LL-37 modulates human neutrophil responses to influenza A virus. J. Leukoc. Biol. 96(5) 931 PMID: 25082153

LL-37 is a member of the large cationic family of anti-microbial peptides called cathelicidins which have broad-spectrum anti-microbial activity and are expressed in many species. The only cathelicidin found in humans is LL-37, this is produced in epithelial cells, by proteolytic cleavage from the C-terminal of the hCAP-18 protein. LL-37 can be processed into different forms of anti-microbial peptides. As well as its anti-microbial properties LL-37 also regulates many aspects of the innate immune system and overexpression of LL-37 has been linked to autoimmune diseases such as asthma and psoriasis, making LL-37 the most studied form of the human cathelicidin peptides.

LL-37 acid

Cat No. Pack Size Price Qty

crb1000007h

0.5mg

$225.00

crb1000007j

1mg

$300.00